Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Rodriguez

Showing results (21-30 of 251) with videos related to

Pageof 26
Sort By:
Expert Review of Neurotherapeutics|March 2, 2010
Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelinationJens Watzlawik, Arthur E Warrington, Moses Rodriguez
Journal of Neuroimmunology|January 27, 2004
The role of cellular immune response in Theiler's virus-induced central nervous system demyelinationM Kariuki Njenga, Cristina Marques, Moses Rodriguez
International Journal of Molecular Sciences|November 8, 2019
Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune CellsGeorge Anderson, Moses Rodriguez, Russel J Reiter
Current Pharmaceutical Design|December 16, 2015
Tryptophan Metabolites and Their Impact on Multiple Sclerosis ProgressionJens O Watzlawik, Bharath Wootla, Moses Rodriguez
International Immunology|March 29, 2003
HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesisMeenakshi Khare, Moses Rodriguez, Chella S David
Neurobiology of Disease|August 5, 2006
Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1betaCharles L Howe, Sonia Mayoral, Moses Rodriguez
Expert Review of Neurotherapeutics|May 14, 2019
Glial cells as therapeutic targets in progressive multiple sclerosisBrandon Wilbanks, L J Maher, Moses Rodriguez
Current Pharmaceutical Design|February 23, 2016
Tryptophan Catabolites and Their Impact on Multiple Sclerosis ProgressionJens O Watzlawik, Bharath Wootla, Moses Rodriguez
Advances in Experimental Medicine and Biology|January 18, 2017
Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis ProgressionBurcu Zeydan, Moses Rodriguez, Orhun H Kantarci
Annals of Neurology|May 6, 2003
Efficient central nervous system remyelination requires T cellsAllan J Bieber, Scott Kerr, Moses Rodriguez
Pageof 26

Showing results (21-30 of 251) with videos related to

Sort By:
Pageof 26
Expert Review of Neurotherapeutics|March 2, 2010
Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelinationJens Watzlawik, Arthur E Warrington, Moses Rodriguez
Journal of Neuroimmunology|January 27, 2004
The role of cellular immune response in Theiler's virus-induced central nervous system demyelinationM Kariuki Njenga, Cristina Marques, Moses Rodriguez
International Journal of Molecular Sciences|November 8, 2019
Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune CellsGeorge Anderson, Moses Rodriguez, Russel J Reiter
Current Pharmaceutical Design|December 16, 2015
Tryptophan Metabolites and Their Impact on Multiple Sclerosis ProgressionJens O Watzlawik, Bharath Wootla, Moses Rodriguez
International Immunology|March 29, 2003
HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesisMeenakshi Khare, Moses Rodriguez, Chella S David
Neurobiology of Disease|August 5, 2006
Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1betaCharles L Howe, Sonia Mayoral, Moses Rodriguez
Expert Review of Neurotherapeutics|May 14, 2019
Glial cells as therapeutic targets in progressive multiple sclerosisBrandon Wilbanks, L J Maher, Moses Rodriguez
Current Pharmaceutical Design|February 23, 2016
Tryptophan Catabolites and Their Impact on Multiple Sclerosis ProgressionJens O Watzlawik, Bharath Wootla, Moses Rodriguez
Advances in Experimental Medicine and Biology|January 18, 2017
Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis ProgressionBurcu Zeydan, Moses Rodriguez, Orhun H Kantarci
Annals of Neurology|May 6, 2003
Efficient central nervous system remyelination requires T cellsAllan J Bieber, Scott Kerr, Moses Rodriguez
Pageof 26